Form 483

My CHS Rx, Inc. Form 483, 2026-06-05

FDA issued a Form 483 to My CHS Rx, Inc. on 2026-06-05 with 4 public-safe observations.

483· Form 483 issuedHuman Drugs4 observations

My CHS Rx, Inc. · Hauppauge, United States · Issued June 5, 2026

Overview

  • 4 public-safe observations are available for this inspection.
  • 4 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

5 Jun 2026
21 CFR 211.130

Procedures are written, and followed

Cited by Luxuly Abraham

5 Jun 2026
21 CFR 211.22(a)

Lack of quality control unit

Cited by Luxuly Abraham

5 Jun 2026
21 CFR 211.25(a)

Training--operations, GMPs, written procedures

Cited by Luxuly Abraham

5 Jun 2026
21 CFR 211.63

Equipment Design, Size and Location

Cited by Luxuly Abraham

Inspected site

MCMy CHS Rx, Inc.Hauppauge, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.130Cited across public-safe Form 483 observations1x
21 CFR 211.22(a)Cited across public-safe Form 483 observations1x
21 CFR 211.25(a)Cited across public-safe Form 483 observations1x
21 CFR 211.63Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 4 observations

The full inspection record, as Atlas holds it, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere